Edgewell reported QQ2 2024 organic results characterized by modest top-line growth and substantial margin expansion. Revenue rose to $599.4 million, with adjusted gross margin expanding by 320 basis points and an overall gross margin of ~43.1%. Adjusted EBITDA reached $99.7 million (GAAP EBITDA $101.1 million) driven by productivity savings and price/revenue management, contributing to a marked earnings uplift with adjusted EPS of $0.88 (GAAP EPS $0.72). Management emphasized that half-year performance supported a raised full-year outlook for EBITDA and EPS, reflecting a durable margin expansion trajectory and ongoing monetization of productivity initiatives. International markets were a bright spot, delivering nearly 6% organic growth, while North America faced softer consumption and drug-channel headwinds, particularly in Wet Shave and FemCare. Management highlighted a multi-brand strategy, accelerated innovation, and brand relaunches (Carefree master brand, Billie body care) as key growth drivers for H2 2024 and into fiscal 2025. Free cash flow remained robust, with $56.1 million operating cash flow in the first half and a net debt leverage ratio of 3.4x, underscoring a solid liquidity position despite a leveraged balance sheet. Overall, Edgewell’s QQ2 results validate its dual priority of accelerating margin accretion while investing selectively behind high-potential growth vectors in Sun, Grooming, and international markets.